18 and older, any sex, with Stress. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Parent/Caregiver Stress 48 to 72 Hours Following Admission to the Pediatric ICUPrimary· 48 - 72 hours after admission of child to PICU
Stress will be assessed using the Short Stress Overload Scale (SOS-S). The SOS-S is a 10 item questionnaire. Items are rated not at all (1) to a lot (5). Ratings are assigned a score and the scores are summed. Summed scores range from 10 - 50 with higher scores indicating greater stress. The SOS-S generates two subscores, Personal Vulnerability (PV) and Event Load (EL), with a score range from 5 to 25 for each. An individual's PV score corresponds to that individual's readiness to take on new stressors. Parents may be asked to complete the questionnaire multiple times depending on how long the
Group
Value
95% CI
Standard Consent
9
5 – 14
Bundled Consent
8
6 – 12
Number of Procedures Performed Without Appropriately Documented ConsentSecondary· At discharge or transfer out of PICU or 30 days after admission to the PICU, whichever comes first.
Number of procedures preformed without recorded consent will be determined by reviewing child's medical chart. Stress will be assessed using the Short Stress Overload Scale (SOS-S). The SOS-S is a 10 item questionnaire. Items are rated not at all (1) to a lot (5). Ratings are assigned a score and the scores are summed. Summed scores range from 10 - 50 with higher scores indicating greater stress. The SOS-S generates two subscores, Personal Vulnerability (PV) and Event Load (EL), with a score range from 5 to 25 for each. An individual's EL score quantifies the stress burden placed on that indiv
Group
Value
95% CI
Standard Consent
11
6 – 15
Bundled Consent
9
6 – 14
Parent/Caregiver Stress at Time of Discharge From the Pediatric ICUSecondary· At discharge or transfer out of PICU or 30 days after admission to the PICU, whichever comes first.
This was assessed by asking parent/caregiver a single question: "How life threatening do you believe your child's illness to be?" The question could be answered 1-5 with 1= not at all and 5= extremely.
Group
Value
95% CI
Standard Consent
3
2 – 5
Bundled Consent
3
2 – 4
Sponsor's own description
The purpose of this research study is to find out about how obtaining consent for procedures in the PICU affects parental/caregiver stress. The researchers think that alleviating some of the uncertainly of a PICU stay by discussing types of procedural support offered and obtaining informed consent prior to their immediate necessity may help decrease stress experienced by caregivers. This study will allow the researchers to learn more about it.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT07485790 — The Effects of Yoga on Pregnant Women
· NA
· recruiting
NCT07469527 — Effects of Feel Free® Classic Tonic on Stress and Pharmacokinetics in Healthy Adults
· NA
· recruiting
NCT07387107 — Decreasing Stress Via Virtual Reality and Binaural Beats in Non-Clinical Adults
· NA
· recruiting
NCT07240792 — Development of a College Student-Delivered Cognitive-Behavioral Therapy (CBT) Intervention for Rural High School Student
· NA
· recruiting
NCT07518056 — Relationships Between Nomophobia Levels and Perceived Stress, Body Image and Food Addiction Among University Students
· recruiting
Other Virginia Commonwealth University trials
Trials by the same sponsor.
NCT05936931 — Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening
· NA
· not yet recruiting
NCT07365839 — Cemiplimab +/- Fianlimab Post Y90 Radioembolization in Patients With Hepatocellular Carcinoma
· Phase 1
· not yet recruiting
NCT07178158 — Enhancing Addiction Treatment Through Psychoeducation
· NA
· not yet recruiting
NCT07531316 — Safety and Tolerability Study of VVZ-2471 in Healthy Volunteers
· Phase 1
· not yet recruiting
NCT07426913 — Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab
· NA
· not yet recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Virginia Commonwealth University
Last refreshed: 12 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04697173.